Anti-influenza A virus activity of flavonoids in vitro: a structure-activity relationship (nov, 10.1007/s11418-022-01660-z, 2022)

被引:0
|
作者
Morimoto, Ryosuke [1 ,4 ]
Hanada, Akari [1 ]
Matsubara, Chiaki [1 ]
Horio, Yuka [1 ]
Sumitani, Hidenobu [2 ]
Ogata, Tokutaro [3 ]
Isegawa, Yuji [1 ]
机构
[1] Mukogawa Womens Univ, Sch Food Sci & Nutr, Dept Food Sci & Nutr, Ikebiraki-cho 6-46, Nishinomiya, Hyogo 6638558, Japan
[2] Toyo Inst Food Technol, Kawanishi, Hyogo 6660026, Japan
[3] Hokuriku Univ, Fac Parmaceut Sci, Kanazawa, Ishikawa 9201180, Japan
[4] Shikoku Univ, Fac Human Life Sci, Tokushima 7711192, Japan
基金
日本学术振兴会;
关键词
Aglycon; Flavonoid; Influenza virus; Natural product; Phytochemical;
D O I
10.1007/s11418-022-01671-w
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Secondary plant metabolites from food extracts, namely daidzein, quercetin, and luteolin, exhibit anti-influenza virus effects, with IC50 values of 143.6, 274.8, and 8.0 μM, respectively. The activities of these metabolites differ depending on the functional groups. Therefore, in this study, we focused on members of the flavonoid group, and investigated the anti-influenza viral effects of different flavonoid classes (flavone, isoflavone, flavonol, flavanone, and flavan-3-ol) in vitro. The IC50 values were 4.9–82.8 μM, 143.6 μM, 62.9–477.8 μM, 290.4–881.1 μM, and 22.9–6717.2 μM, respectively, confirming their activity. The modifying group factors (number, position, type) in the flavonoid skeleton may be significantly related to the anti-influenza virus activity. Moreover, time-of-addition assay revealed that the mechanism of inhibition varied for the different classes; for example, flavonoids that inhibit virus adsorption or the early stage of viral growth. Interestingly, all the examined flavonoids inhibited the late stages of viral growth, suggesting that flavonoids mainly inhibit the late events in viral growth before the release of viral particles. Additionally, apigenin might be effective against oseltamivir-resistant strains. Our results may be important in the development of anti-influenza virus therapeutic strategies in the future. Graphical abstract: [Figure not available: see fulltext.] © 2022, The Author(s) under exclusive licence to The Japanese Society of Pharmacognosy.
引用
收藏
页码:228 / 229
页数:2
相关论文
共 22 条
  • [1] Anti-influenza A virus activity of flavonoids in vitro: a structure–activity relationship
    Ryosuke Morimoto
    Akari Hanada
    Chiaki Matsubara
    Yuka Horio
    Hidenobu Sumitani
    Tokutaro Ogata
    Yuji Isegawa
    Journal of Natural Medicines, 2023, 77 : 219 - 227
  • [2] Correction: Anti-influenza A virus activity of flavonoids in vitro: a structure–activity relationship
    Ryosuke Morimoto
    Akari Hanada
    Chiaki Matsubara
    Yuka Horio
    Hidenobu Sumitani
    Tokutaro Ogata
    Yuji Isegawa
    Journal of Natural Medicines, 2023, 77 : 228 - 229
  • [3] Structure-activity relationship analysis of curcumin analogues on anti-influenza virus activity
    Ou, Jun-Lin
    Mizushina, Yoshiyuki
    Wang, Sheng-Yang
    Chuang, Duen-Yau
    Nadar, Muthukumar
    Hsu, Wei-Li
    FEBS JOURNAL, 2013, 280 (22) : 5829 - 5840
  • [4] Anti-influenza A virus activity and structure-activity relationship of a series of nitrobenzoxadiazole derivatives
    Fiorentino, Francesco
    De Angelis, Marta
    Menna, Martina
    Rovere, Annarita
    Caccuri, Anna Maria
    D'Acunzo, Francesca
    Palamara, Anna Teresa
    Nencioni, Lucia
    Rotili, Dante
    Mai, Antonello
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2021, 36 (01) : 2128 - 2138
  • [5] Structure-activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities
    Liu, Ai-Lin
    Wang, Hai-Di
    Lee, Simon MingYuen
    Wang, Yi-Tao
    Du, Guan-Hua
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (15) : 7141 - 7147
  • [6] Anti-influenza virus activity and structure-activity relationship of aglycoristocetin derivatives with cyclobutenedione carrying hydrophobic chains
    Naesens, Lieve
    Vanderlinden, Evelien
    Roth, Erzsebet
    Jeko, Jozsef
    Andrei, Graciela
    Snoeck, Robert
    Pannecouque, Christophe
    Illyes, Eszter
    Batta, Gyula
    Herczegh, Pal
    Sztaricskai, Ferenc
    ANTIVIRAL RESEARCH, 2009, 82 (01) : 89 - 94
  • [7] Discovery of anti-influenza A virus activity of a corynanthe-type indole alkaloid, hirsutine, in vitro and the structure-activity relationship of natural and synthetic analogs
    Takayama, H
    Iimura, Y
    Kitajima, M
    Aimi, N
    Konno, K
    Inoue, H
    Fujiwara, M
    Mizuta, T
    Yokota, T
    Shigeta, S
    Tokuhisa, K
    Hanasaki, Y
    Katsuura, K
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (24) : 3145 - 3148
  • [8] Structure-activity relationship studies of lipophilic teicoplanin pseudoaglycon derivatives as new anti-influenza virus agents
    Szucs, Zsolt
    Kelemen, Viktor
    Thai, Son Le
    Csavas, Magdolna
    Roth, Erzsebet
    Batta, Gyula
    Stevaert, Annelies
    Vanderlinden, Evelien
    Naesens, Lieve
    Herczegh, Pal
    Borbas, Anik
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 157 : 1017 - 1030
  • [9] Synthesis, structure activity relationship and in vitro anti-influenza virus activity of novel polyphenol-pentacyclic triterpene conjugates
    Li, Haiwei
    Li, Man
    Xu, Renyang
    Wang, Shouxin
    Zhang, Yongmin
    Zhang, Lihe
    Zhou, Demin
    Xiao, Sulong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 163 : 560 - 568
  • [10] Anti-Influenza Drug Discovery: Structure-Activity Relationship and Mechanistic Insight into Novel Angelicin Derivatives
    Yeh, Jiann-Yih
    Coumar, Mohane Selvaraj
    Horng, Jim-Tong
    Shiao, Hui-Yi
    Kuo, Fu-Ming
    Lee, Hui-Ling
    Chen, In-Chun
    Chang, Chun-Wei
    Tang, Wen-Fang
    Tseng, Sung-Nain
    Chen, Chi-Jene
    Shih, Shin-Ru
    Hsu, John T. -A
    Liao, Chun-Chen
    Chao, Yu-Sheng
    Hsieh, Hsing-Pang
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (04) : 1519 - 1533